CIK 0001093557
- Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330857544
- Phone
- +1 858-200-0200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-02 | SAYER KEVIN R President, CEO and Chairman | Sale | −900 | $220.95 | $199K | 209,057 |
| 2019-12-02 | SAYER KEVIN R President, CEO and Chairman | Sale | −3,992 | $222.12 | $887K | 205,065 |
| 2019-12-02 | SAYER KEVIN R President, CEO and Chairman | Sale | −2,128 | $222.76 | $474K | 202,937 |
| 2019-11-22 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −1,300 | $217.39 | $283K | 15,544 |
| 2019-11-22 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −233 | $218.52 | $51K | 15,311 |
| 2019-11-22 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −1,300 | $217.39 | $283K | 79,451 |
| 2019-11-22 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −232 | $218.52 | $51K | 79,219 |
| 2019-11-21 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −1,318 | $218.43 | $288K | 79,232 |
| 2019-11-21 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −3,037 | $219.65 | $667K | 76,195 |
| 2019-11-21 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −4,259 | $220.50 | $939K | 71,936 |
| 2019-11-21 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −2,990 | $221.16 | $661K | 68,946 |
| 2019-11-07 | AUGUSTINOS NICHOLAS Director | Sale | −1,208 | $185.29 | $224K | 6,854 |
| 2019-11-04 | SAYER KEVIN R President, CEO and Chairman | Sale | −3,030 | $156.75 | $475K | 219,907 |
| 2019-11-04 | SAYER KEVIN R President, CEO and Chairman | Sale | −4,470 | $157.42 | $704K | 215,437 |
| 2019-11-04 | SAYER KEVIN R President, CEO and Chairman | Sale | −2,500 | $158.57 | $396K | 212,937 |
| 2019-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −633 | $151.70 | $96K | 17,744 |
| 2019-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −800 | $152.71 | $122K | 16,944 |
| 2019-10-23 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −100 | $153.34 | $15K | 16,844 |
| 2019-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −641 | $151.69 | $97K | 81,642 |
| 2019-10-23 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −681 | $152.71 | $104K | 80,961 |
Page 68 of 72 · 1,429 trades